Effect of Locally Applied Electricity On Clot Formation and Hemostasis.

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 2220-2220 ◽  
Author(s):  
Elaissa Hardy ◽  
Yumiko Sakurai ◽  
Nadia Sanjaya ◽  
Alisa S. Wolberg ◽  
Wilbur Lam

Abstract Abstract 2220 Background: Electricity has historically been used in medical applications such as defibrillators, cauterization, and electrosurgery. Additionally, Kalghatgi et al. [1] demonstrate that high voltage electrical fields (∼30 kilo volts) activate platelets and induce coagulation. However, the exact effect of applied electrical current on clot formation is unknown. We show that upon direct application of electricity (voltages between 5 – 40 volts), platelets are activated immediately and clots rapidly form without excessive heating. This newfound application to induce blood clot formation may enable a new and novel class of therapeutics to achieve hemostasis at sites of bleeding. As newer hemostatic agents are currently derived from animal or human products, which carry risk of blood borne infections and immune dysregulation, a clear need exists for novel therapies to achieve hemostasis. Method: Our experimental setup consisted of a silicone polydimethylsiloxane (PDMS) chamber with embedded metallic wires (Figure 1A). The metallic leads were connected to an Agilent E3649A variable power supply and a constant voltage was applied to the chamber for 1 minute. A Fluke 179 multimeter monitored the temperature with a thermocouple lead inserted into the liquid in the chamber. Experiments were conducted using whole human blood, platelet rich plasma (PRP), platelet poor plasma (PPP), and isolated, washed platelets. Additionally, fluorescently labeled fibrinogen (Alexa Fluor 488) was added to the blood product, 5%v/v, to assess fibrin formation. Experiment: Initial experiments characterized the electrical characteristics of the different components of blood pertinent for clot formation to assess the potential safety concerns. Voltages between 5 – 40 volts (V) result in currents below 0.1 amps (A) and temperatures between 20 – 50°C. Nominally, current values of 0.1A and greater are considered deadly [2], and thermal tissue damage caused by temperatures below 45°C are considered reversible [2], therefore the majority of our work focuses on voltages less than 30V. Figure 1B shows the timeline of fibrin network formation for a control whole blood sample versus a whole blood sample exposed to 30V for 60 seconds. At 30V and immediately after electrical stimulus, platelet aggregation begins to form. At 120 seconds, fibrin polymerization initiates and showed complete coverage at 180 seconds, as well as numerous clusters of platelet aggregates. In the absence of electrical stimulus, no fibrin polymerization or platelet aggregation was detected until greater than 240 seconds and full network coverage was complete by 420 second. Platelet aggregration was more pronouced with electrical stimulus, as compared to the control case. Various voltages were tested with the mean time to complete the fibrin network formation in stimulated and unstimulated whole blood was 170 seconds vs. 320 seconds, respectively (n = 3) indicating a 53% increase in fibrin formation and platelet aggregation. Additional experiments were conducted on anti-coagulated PPP, PRP, and isolated, washed platelets showing no evidence of fibrin polymerization. This suggests that all the components in blood are necessary to create the fibrin scaffold when exposed to electricity. Continued work will focus on unraveling the underlying mechanisms of how electrical stimulation affects platelet aggregation and coagulation. Conclusion: Our results suggest that direct electrical stimulation promotes clot formation and could potentially lead to a new category of hemostatic therapies that are free from the infectious risks and immune effects that encumber current human or animal-derived agents. With the addition of electrical stimulus, fibrin networks form on average 53% faster than control conditions. We anticipate this concept of applying electricity to different processes in the blood will have significant implications for experimental and clinical hematology. Disclosures: No relevant conflicts of interest to declare.

2014 ◽  
Vol 9 (9) ◽  
pp. 592-595
Author(s):  
Yaw‐Jen Chang ◽  
Ching‐Wei Huang

2015 ◽  
Vol 62 (2) ◽  
pp. 708-716 ◽  
Author(s):  
Jaime Punter-Villagrasa ◽  
Joan Cid ◽  
Jordi Colomer-Farrarons ◽  
Ivon Rodriguez-Villarreal ◽  
Pere Ll. Miribel-Catala

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 4038-4038
Author(s):  
Meera Chitlur ◽  
Erin Ware ◽  
Sujata Kannan ◽  
Wendy Hollon ◽  
Steve Buck ◽  
...  

Abstract Dendritic polymers are branched nanopolymers with a central core and multiple peripheral functional groups that offer great potential as high payload delivery vehicles carrying multiple copies of drug molecules, targeting ligands and imaging agents to their site of action. Their nanoscopic dimensions offer exciting possibilities for achieving high intracellular drug concentrations in many therapeutic areas including anti-cancer drug delivery. Biocompatibility and biodistribution of dendritic polymers may be influenced by surface charge and concentration. One of the major challenges in their use is the effect on coagulation. The objective of this study was to determine the effect of change in surface charge and concentration of dendritic polymer on cellular and enzymatic components of coagulation. Materials and Methods: The effect of increasing concentrations (1, 10, 100, and 1000mcg/ml) of polyamidoamine (PAMAM) dendrimers with -COOH (anionic), -OH (neutral), and -NH2 (cationic) end functionalities, on platelet function and coagulation was evaluated using thromboelastography, whole blood aggregation, and flow cytometry. The thromboelastographic profile and platelet aggregation studies were obtained on samples of whole blood incubated for thirty minutes with dendrimer. Platelets were incubated with FITC labelled dendrimer for 30,60 and 120 mins, to determine uptake and platelet activation using flow cytometry. All tests were performed in triplicate. RESULTS: Thromboelastography: No significant effect on clot formation (time to clot formation and size) was seen with PAMAM-COOH (COOH) or PAMAM-OH (OH). Prolonged time to initiation of clot and decreased size were noted with 100 and 1000mcg/ml of PAMAM-NH2(NH2) as shown in figure1, indicating impairment of both the enzymatic and cellular components of the coagulation system. Whole Blood Aggregation: Neither platelet aggregation nor secretion were significantly affected by COOH or OH. Platelet aggregation was significantly decreased with NH2 at 100 and 1000mcg/ml. Flow Cytometry: Spontaneous CD62 activation was seen in platelets incubated with NH2. No spontaneous CD62 activation was noted with COOH or OH even at 1000mcg/ml. Platelet uptake of FITC labeled dendrimer was assessed at 30, 60 and 120mins of incubation. Increased uptake of FITC labeled dendrimer was noted at 2 hours with NH2. TEG clotting Profiles with PAMAM-NH2. TEG clotting Profiles with PAMAM-NH2. CONCLUSIONS: Surface charge of the dendritic nanopolymers plays a significant role on its effect on coagulation and platelet function. The anionic -COOH terminated and neutral -OH terminated dendrimers had no effect on hemostasis even at the highest concentrations while the cationic-NH2 was associated with inhibition of platelet aggregation and delayed clot initiation at higher concentrations. This would indicate that the anionic and neutral dendrimers would serve as better vehicles than cationic dendrimers for targeted delivery of therapeutic agents.


2017 ◽  
Vol 17 (21) ◽  
pp. 7149-7156 ◽  
Author(s):  
Animesh Halder ◽  
Probir Kumar Sarkar ◽  
Poulomi Pal ◽  
Subhananda Chakrabarti ◽  
Prantar Chakrabarti ◽  
...  

1972 ◽  
Vol 56 (2) ◽  
pp. 501-507
Author(s):  
P. D. EVANS

1. The presence of a large intracellular pool of free amino acids in the haemocytes of Carcinus maenas (L.) is described. It was found that 58 % of the total free amino acid concentration of a whole-blood sample was present in the cell fraction. 2. The blood-cell count for Carcinus was found to be around 33,000 cells/µl which corresponded to 1 % by volume of the whole-blood sample. Thus 58 % of the total free amino acid concentration of the blood sample is sequestered into 1 % of the total volume. 3. The pattern of the amino acid pool of the haemocytes is shown to differ from that of muscle and nervous tissue from Carcinus. In particular, the taurine molecule accounted for 50 % of the pool in the haemocytes. 4. Possible functions for the amino acids of the haemocyte pool are suggested and the results are discussed in relation to other studies on free amino acids in crustacean blood.


1999 ◽  
Author(s):  
Rhonda Cheadle ◽  
Andy Maczuszenko ◽  
Cindra Widrig Opalsky

Abstract The following describes the development of a disposable cartridge for use at the patient bedside to perform traditional coagulation assays on fresh whole blood samples. The cartridge provides a means by which a blood sample can be metered and quantitatively mixed with reagents that activate the coagulation cascade. Clot formation is subsequently detected using a microfabricated sensor housed within the cartridge. The functional features of the cartridge and sensor are described.


Sign in / Sign up

Export Citation Format

Share Document